Th17 cells have paradoxical functions; they indirectly enhance antitumor immunity by inducing effector cell recruitment, activating tumor-specific cytotoxic CD8+ T lymphocytes, and transforming to the Th1 phenotype. This evidence concerns the gene CD8A and neoplasm.